7 completed, 2 recruiting, 2 terminated, 1 enrolling by invitation. 14 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 14 | Completed 7, Recruiting 2, Terminated 2, Enrolling by invitation 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
Follow Hereditary Autoinflammatory Diseases: new trials by email Literature Review of Hereditary Autoinflammatory Diseases trials Research Report on Hereditary Autoinflammatory Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS) JTE-162 - Cryopyrin-associated Periodic Syndromes (CAPS) | Phase 1 | Completed | Akros Pharma Inc. | 5 | 2026-02-02 | 2026-10-09 |
| Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load 124I AT-01 - Cryopyrin-Associated Periodic Syndromes, Amyloidosis | Phase 1 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2025-09-10 | 2026-05-19 |
| Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) RAY121 - Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP) | Phase 1 | Enrolling by invitation | Chugai Pharmaceutical | 144 | 2024-12-09 | 2026-07-17 |
| Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) RAY121 - Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP) | Phase 1 | Recruiting | Chugai Pharmaceutical | 144 | 2024-08-19 | 2026-07-22 |
| Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334 IZD334, Placebos - Healthy Volunteers, Cryopyrin Associated Periodic Syndrome | Phase 1 | Completed | Inflazome UK Ltd | 64 | 2019-09-13 | 2020-03-02 |
| Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) Canakinumab - Periodic Fever | Phase 1 | Unknown | Rabin Medical Center | 10 | 2016-08-01 | 2018-09-04 |
| A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study HL2351, Kineret(Anakinra) - Healthy Volunteers | Phase 1 | Completed | Handok Inc. | 58 | 2014-05-01 | 2015-10-06 |
| Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study Intravitreal Infliximab - Behçet's Disease, Uveitis | Phase 1 / Phase 2 | Completed | Cairo University | 20 | 2013-01-01 | 2015-12-03 |
| Anakinra for Behcet s Disease Anakinra - Autoimmune Connective Tissue Disorder, Immune System Diseases | Phase 1 / Phase 2 | Completed | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 6 | 2011-09-01 | 2017-05-12 |
| A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease XOMA 052 - Muckle Wells Syndrome, Autoinflammatory | Phase 1 / Phase 2 | Withdrawn | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2010-08-27 | 2017-07-02 | |
| Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients colchicine sprinkle capsules - Familial Mediterranean Fever | Phase 1 | Completed | Mutual Pharmaceutical Company, Inc. | 75 | 2010-08-01 | 2012-01-10 |
| Stem Cell Transplantation in Ocular Lesions of Behcet's Disease Autologous Stem Cell Transplantation - Retinitis, Behcet's Syndrome | Phase 1 | Terminated | Tehran University of Medical Sciences | 5 | 2007-12-01 | 2015-11-10 |
| The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria Kineret (anakinra) - Familial Cold Urticaria | Phase 1 | Completed | Nova Scotia Health Authority | 8 | 2005-09-01 | 2022-11-08 |
| Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease anakinra - Nervous System Malformations, Arthropathy, Neurogenic | Phase 1 / Phase 2 | Terminated | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 43 | 2003-09-01 | 2016-12-01 |
Cryopyrin-Associated Periodic Syndromes (7) · Behcet Syndrome (6) · Antiphospholipid Syndrome (2) · Dermatomyositis (2) · Papilledema (2) · Pemphigoid, Bullous (2) · Purpura, Thrombocytopenic, Idiopathic (2) · Uveitis (2) · Amyloidosis (1) · Arthritis, Rheumatoid (1) · Arthropathy, Neurogenic (1) · Congenital Abnormalities (1) · Familial Mediterranean Fever (1) · Immune System Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (14) · Genetic Diseases, Inborn (14) · Skin Diseases (13) · Skin Diseases, Genetic (13) · Skin and Connective Tissue Diseases (13) · Skin Diseases, Vascular (12) · Immune System Diseases (9) · Pathologic Processes (9) · Pathological Conditions, Signs and Symptoms (9) · Chronic Disease (7) · Chronic Inducible Urticaria (7) · Chronic Urticaria (7) · Cold Urticaria (7) · Disease Attributes (7)
Interleukin 1 Receptor Antagonist Protein (4) · canakinumab (1) · gevokizumab (1)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (3) · Chugai Pharmaceutical (2) · Akros Pharma Inc. (1) · Cairo University (1) · Handok Inc. (1) · Inflazome UK Ltd (1) · Mutual Pharmaceutical Company, Inc. (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Nova Scotia Health Authority (1) · Rabin Medical Center (1) · Tehran University of Medical Sciences (1)
United States (6) · Canada (4) · Australia (3) · Turkey (Türkiye) (3) · Austria (2) · Bulgaria (2) · Croatia (2) · Czechia (2) · France (2) · Germany (2) · Hungary (2) · Israel (2) · Italy (2) · Japan (2) · Netherlands (2)
Behrouz Nikbin, MD (1) · Fereydoun Davatchi, MD (1) · Hormoz Shams, MD (1) · Hyeong Ki Lee, Professor (1) · Jason Lickliter, MBBS, PhD (1) · Liora Harel, MD (1) · Mahmoud Soliman, MD PhD (1) · Matthew Davis, MD (1) · Peter C Grayson, M.D. (1) · Raphaela T Goldbach-Mansky, M.D. (1) · Sara Alehashemi, M.D. (1)
PMID 16899778, PMID 22294344, PMID 23773637, PMID 25223501, PMID 27143789, PMID 28118536, PMID 28335798
ZIAAR041138-08 (1)